N06DA Anticholinesterase anti-dementia drugs
ATC group of level 4 – chemical subgroup · in plain English: medicines for dementia, e.g. Alzheimer's disease
This site has the patient leaflet or the SPC of 128 medicines in this group and its subgroups.
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- N Nervous system drugs 4,479 medicines
- N06 Psychoanaleptics 766 medicines
- N06D Anti-dementia drugs 193 medicines
-
N06DA Anticholinesterase anti-dementia drugs 128 medicines
- N06DA02 donepezil 15 medicines
- N06DA03 rivastigmine 80 medicines
- N06DA04 galantamine 33 medicines
-
N06DA Anticholinesterase anti-dementia drugs 128 medicines
- N06D Anti-dementia drugs 193 medicines
- N06 Psychoanaleptics 766 medicines
4 more subgroups have no medicine with a leaflet on this site.
Medicines in the group and its subgroups
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N06DA
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
